doi: 10.1016/j.intimp.2024.113817 41 HuangXGengHLiangCXiongXDuXZhuanQet al
He reports research funding to his institution by CIHR, Breakthrough T1D, the Kidney Foundation of Canada, Mitacs Inc, NorWest Co-op Community Health, PepsiCo Inc, The Weston Family Foundation, and the Winnipeg Foundation, outside the submitted work
Once-Weekly Convenience Single weekly injection significantly improves patient compliance compared to daily injectable therapies, making long-term adherence easier for patients
When patients showed signs of bacteremia, their physicians ordered daily blood samples to test for bacterial growth
Other dangerous side effects include inflammation of the pancreas, serious allergic reactions, severe stomach problems, dehydration, changes in vision, gallbladder problems, kidney problems